Patients with immune dysregulation (dCVID) had significantly lower CD4 cell counts at diagnosis (643.57 cells/μL, SD 476.05) compared to patients without immune dysregulation (747.51 cells/μL, SD 306.49) (p=0.016), regardless of the presence of cancer. The gene discussed is CD4; the disease is cancer.